Private Capital Group’s iShares Biotechnology ETF IBB Stock Holding History

Private Capital Group’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-345	Closed	-$45K	–	1981
2022 Q1	$45K	Hold	345	–	–	0.01%	686
2021 Q4	$53K	Hold	345	–	–	0.01%	655
2021 Q3	$56K	Hold	345	–	–	0.01%	624
2021 Q2	$57K	Hold	345	–	–	0.01%	623
2021 Q1	$52K	Sell	345 -15	-4%	-$2.38K	0.01%	626
2020 Q4	$55K	Sell	360 -447	-55%	-$63.9K	0.01%	736
2020 Q3	$109K	Buy	807 +15	+2%	+$2.04K	0.02%	426
2020 Q2	$108K	Buy	792 +447	+130%	+$57K	0.02%	421
2020 Q1	$37K	Hold	345	–	–	0.01%	766
2019 Q4	$41K	Hold	345	–	–	0.01%	824
2019 Q3	$34K	Hold	345	–	–	0.01%	950
2019 Q2	$38K	Hold	345	–	–	0.01%	788
2019 Q1	$39K	Sell	345 -200	-37%	-$21.9K	0.01%	894
2018 Q4	$53K	Hold	545	–	–	0.01%	632
2018 Q3	$66K	Hold	545	–	–	0.01%	594
2018 Q2	$59K	Buy	545 +200	+58%	+$21.4K	0.01%	624
2018 Q1	$37K	Hold	345	–	–	0.01%	818
2017 Q4	$37	Buy	+345	New	+$36.9K	0.01%	807

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Private Capital Group's IBB Position: Q2 2022 in Review

Private Capital Group sold out of iShares Biotechnology ETF (IBB) in Q2 2022, closing a stake of 345 shares — an estimated $45K sold.

Private Capital Group first reported a position in IBB in Q4 2017 and held it in 18 quarters. The position peaked at $109K in Q3 2020. 859 funds tracked by Wall St. Rank hold IBB as of Q2 2022.

Private Capital Group reported no remaining iShares Biotechnology ETF position as of Q2 2022 after selling out during the quarter.
Private Capital Group sold 345 iShares Biotechnology ETF shares in Q2 2022, an estimated $45K.
Private Capital Group first reported a position in iShares Biotechnology ETF in Q4 2017 and held it in 18 quarters.
Private Capital Group's iShares Biotechnology ETF position peaked at $109K in Q3 2020.
859 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.